Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001157523-09-002158
Filing Date
2009-03-17
Accepted
2009-03-17 16:28:48
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 ORE PHARMACEUTICALS, INC. 10-K a5915889.htm 10-K 1139948
2 EXHIBIT 3.1 a5915889ex3_1.htm EX-3.1 92138
3 EXHIBIT 10.2 a5915889_ex102.htm EX-10.2 112904
4 EXHIBIT 10.58B a5915889ex10_58b.htm EX-10.58B 28351
5 EXHIBIT 23.1 a5915889ex23_1.htm EX-23.1 35128
6 EXHIBIT 31 a5915889ex_31.htm EX-31 33613
7 EXHIBIT 32 a5915889ex_32.htm EX-32 11290
  Complete submission text file 0001157523-09-002158.txt   1454778
Mailing Address 50 WEST WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address 50 WEST WATKINS MILL ROAD GAITHERSBURG MD 20878 3019871700
GENE LOGIC INC (Filer) CIK: 0001043914 (see all company filings)

EIN.: 061411336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23317 | Film No.: 09688331
SIC: 2835 In Vitro & In Vivo Diagnostic Substances